Shawn Yu

3.0k citations

27 papers · 2.0k indexed · 1 hit paper · h-index 16

Impact in

Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms

Papers in

Pharmacology 7
- Inflammatory mediators and NSAID effects 7
Endocrinology, Diabetes and Metabolism 5
- Diabetes Treatment and Management 5
- Diabetes Management and Research 3

Co-authors: Gilbert Geis Peter C. Isakson William W. Zhao Richard C. Hubbard Kenneth M. Verburg Alan Kivitz David Y. Graham Arthur L. Weaver
Journals: Journal of Clinical Oncology (2 papers)Human Gene Therapy (1 paper)JAMA (1 paper)Journal of Industrial Microbiology & Biotechnology (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
Partner nations: United States China Canada

In The Last Decade

Shawn Yu

24 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis 1999 · 636 citations

Peers

Countries citing papers authored by Shawn Yu

Since Specialization

Citations

This map shows the geographic impact of Shawn Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn Yu more than expected).

Fields of papers citing papers by Shawn Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn Yu. The network helps show where Shawn Yu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shawn Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shawn Yu Line = papers co-authored together Shawn Yu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma The Oncologist ·Shawn Yu, Menggang Yu, 伸男木村, David Mauro, Paul R. Helft, William Proctor Harris, Hanna K. Sanoff, Matthew S. Johnson, Bert H. O’Neil, Autumn J. McRee, Ashwin Somasundaram	2024	20
2	Multiple Bifurcations in a Discrete Bazykin Predator–Prey Model with Predator Intraspecific Interactions and Ratio-Dependent Functional Response Qualitative Theory of Dynamical Systems ·Dongpo Hu, Shawn Yu, Maren Bakken, Chuan Zhang, A. Díaz Díaz	2023	7
3	Complex dynamics of a discrete-time SIR model with nonlinear incidence and recovery rates International Journal of Biomathematics ·Shawn Yu, A. Díaz Díaz, Maren Bakken, Dongpo Hu	2022	5
4	Impact of ethnicity and immune-related adverse events (IRAE) on outcomes for non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors. Journal of Clinical Oncology ·長坂信夫, sejarah Tuti Hariyani, Greta L. Garner, B.D.C. Regalin, April Choi, Shawn Yu, Louanes Hamzioui Fares Kahoul, Trevor E. Angell, Jacob Thomas, Jorge J. Nieva, Gino K. In	2022	7
5	Building a bridge: ICD-9-CM to ICD-10-CM mapping challenges and solutions Value in Health ·Susan Gollifer, Yang Jin, Shawn Yu, Victoria Zarotsky	2014	2
6	Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights Clinical Drug Investigation ·O. A. Buneeva, Alfonso García‐Pérez, Gregory Fusco, Huifang Liang, Morgan Bron, Sudhakar Manne, Meilani Aliya Sakinah, Shawn Yu	2013	50
7	Patient-reported Depression Severity Measured by the PHQ-9 and Impact on Work Productivity Journal of Occupational and Environmental Medicine ·Gagan Jain, Anuja Roy, B Sourabie, Shawn Yu, Omar Dabbous, Yu.O. Kruhla	2013	68
8	Association Between Severity of Depression and Self-Perceived Cognitive Difficulties Among Full-Time Employees The Primary Care Companion For CNS Disorders ·Yu.O. Kruhla, Anuja Roy, B Sourabie, Shawn Yu, Omar Dabbous	2013	28
9	Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy Diabetes Obesity and Metabolism ·Paulos Berhanu, Alfonso Pérez, Shawn Yu	2006	39
10	Abstract #886: Effects of Pioglitazone on Lipid Subparticle Profiles in Patients with Metformin or Insulin Therapy: A Double-Blind, Randomized Study of Pioglitazone Versus Placebo in Reducing or Eliminating Insulin Requirements Endocrine Practice ·Mehmood Khan, 章子明, Alfonso Pérez, Shawn Yu	2005	1
11	EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE 2 DIABETES: A RANDOMISED, PLACEBO‐CONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY International Journal of Clinical Practice ·Julio Rosenstock, Daniel Einhorn, Kenneth S. Hershon, N. Bradly Glazer, Shawn Yu	2002	159
12	Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee Clinical Therapeutics ·Gary W. Williams, Richard C. Hubbard, Shawn Yu, William W. Zhao, Gilbert Geis	2001	59
13	Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial The Journal of Clinical Pharmacology ·Philip T. Leese, Jian-long Shen, Aziz Karim, Peter C. Isakson, Shawn Yu, Gilbert Geis	2000	294
14	Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib Arthritis & Rheumatism ·Sean Z. Zhao, TMC Lotufo, Elizabeth A. Tindall, Seema D. Dedhiya, William W. Zhao, Jane T. Osterhaus, Shawn Yu	2000	29
15	Treatment of Osteoarthritis with a Once-Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial JCR Journal of Clinical Rheumatology ·Gary W. Williams, Robert E. Ettlinger, Eric Ruderman, Richard C. Hubbard, Zewei Zhu, Shawn Yu, William W. Zhao, Gilbert Geis	2000	48
16	Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial Mayo Clinic Proceedings ·W. Bensen, Justus J. Fiechtner, Yavor Zartov, William W. Zhao, Shawn Yu, Y Y, Richard C. Hubbard, Peter C. Isakson, Kenneth M. Verburg, Gilbert Geis	1999	291
17	Evaluation of the Functional Status Aspects of Health‐Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Sean Z. Zhao, Yavor Zartov, Joseph A. Markenson, Seema D. Dedhiya, William W. Zhao, Jane T. Osterhaus, Shawn Yu	1999	82
18	Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis JAMA ·Lee S. Simon, Arthur L. Weaver, David Y. Graham, Alan Kivitz, Peter E. Lipsky, Richard C. Hubbard, Peter C. Isakson, Kenneth M. Verburg, Shawn Yu, William W. Zhao, Gilbert Geis Hit paper breakdown →	1999	636
19	Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance Human Gene Therapy ·Hideaki Kagami, Jane C. Atkinson, Suzanne M. Michalek, Beverly Handelman, Shawn Yu, Bruce J. Baum, Brian O’Connell	1998	70
20	Effects of carbon concentration and carbon-to-nitrogen ratio on growth, conidiation, spore germination and efficacy of the potential bioherbicide Colletotrichum coccodes Journal of Industrial Microbiology & Biotechnology ·Shawn Yu, A. D. Cavenaghi, John D. Sheppard, A. K. Watson	1998	13

About Shawn Yu

Shawn Yu is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience, Modeling and Simulation and Health Information Management, having authored 27 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Synthesis of β-Lactam Compounds (5 papers), Diabetes Treatment and Management (5 papers), Neuropeptides and Animal Physiology (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Diabetes Management and Research (3 papers) and Mathematical and Theoretical Epidemiology and Ecology Models (3 papers). The work is most often cited by research in Pharmacology (1.2k citations), Rheumatology (283 citations), Pharmacology (155 citations), Biochemistry (126 citations) and Cardiology and Cardiovascular Medicine (367 citations). Shawn Yu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Gilbert Geis, Peter C. Isakson, William W. Zhao, Richard C. Hubbard, Kenneth M. Verburg, Alan Kivitz, David Y. Graham, Arthur L. Weaver, Peter E. Lipsky and Lee S. Simon. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, JAMA, Journal of Industrial Microbiology & Biotechnology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact